KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Buildings (2016 - 2026)

Boston Scientific's Buildings history spans 18 years, with the latest figure at $2.5 billion for Q1 2026.

  • On a quarterly basis, Buildings rose 20.13% to $2.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.5 billion, a 20.13% increase, with the full-year FY2025 number at $2.5 billion, up 23.03% from a year prior.
  • Buildings hit $2.5 billion in Q1 2026 for Boston Scientific, up from $2.5 billion in the prior quarter.
  • Over the last five years, Buildings for BSX hit a ceiling of $2.5 billion in Q3 2025 and a floor of $1.4 billion in Q2 2022.
  • Historically, Buildings has averaged $1.9 billion across 5 years, with a median of $1.9 billion in 2024.
  • Biggest five-year swings in Buildings: rose 4.77% in 2022 and later surged 32.64% in 2025.
  • Tracing BSX's Buildings over 5 years: stood at $1.7 billion in 2022, then grew by 8.73% to $1.8 billion in 2023, then increased by 9.55% to $2.0 billion in 2024, then rose by 23.03% to $2.5 billion in 2025, then rose by 1.37% to $2.5 billion in 2026.
  • Business Quant data shows Buildings for BSX at $2.5 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.5 billion in Q3 2025.